Home / Resource Library / Phase 1 Trial of Prizloncabtagene Autoleucel, a CD19/20 CAR-T for Relapsed/Refractory B-Cell Non-Hodgkin LymphomaPhase 1 Trial of Prizloncabtagene Autoleucel, a CD19/20 CAR-T for Relapsed/Refractory B-Cell Non-Hodgkin Lymphoma